Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Osteoporosis Health Center

Font Size

FDA: Osteoporosis Drugs May Raise Thigh Fracture Risk

Actonel, Atelvia, Boniva, Fosamax, Reclast Carry Possible Fracture Risk
WebMD Health News
Reviewed by Laura J. Martin, MD

Oct. 13, 2010 -- The bisphosphonate class of osteoporosis drugs -- including Actonel, Atelvia, Boniva, Fosamax, Reclast, and generics -- may raise the risk of thigh bone fracture, the FDA warns.

There's no proof that the drugs cause the rare, serious thigh fractures called atypical femur fractures. But these events are more common in patients taking bisphosphonates than in patients taking other osteoporosis drugs.

For that reason, the FDA today issued a warning to patients. That warning will appear on the drugs' labels.

It appears that the risk is related to use of bisphosphonates for longer than five years.

Patients who have these unusual fractures often report a dull ache in their thigh or groin in the weeks or months preceding the actual fracture.

That pain may be the only warning. These atypical fractures occur almost by themselves, with little or no reported trauma to the thigh.

It's possible for these fractures to occur in osteoporosis patients who are not taking bisphosphonates, Sandra Kweder, MD, deputy director of the FDA's office of new drugs, said at a news teleconference.

But Kweder stressed that atypical fractures are rare -- and that bisphosphonates have been shown to significantly reduce the overall risk of bone fractures due to osteoporosis.

"This should not cause patients to become fearful of their medications. Bisphosphonates have prevented many fractures in the years of their use," she said.

The warning is only for bisphosphonates used for osteoporosis prevention, and not for Paget's disease or cancer.

Last March, the FDA announced that it was investigating bisphosphonates. Today's warning is a direct result of this continuing investigation.

"The FDA is continuing to evaluate data about the safety and effectiveness of bisphosphonates when used long term for osteoporosis treatment," Kweder said. "In the interim, it's important for patients and health care professionals to have all the safety information available."

Today on WebMD

Women working out and walking with weights
Reduce bone loss and build stronger muscles.
Chinese cabbage
Calcium-rich foods to add to your diet.
woman stretching
Get the facts on osteoporosis.
Porous bone
Causes, symptoms, risk factors, and treatment.
senior woman
Woman holding plate of brocolli
wrist xray
Superfood for Bones
mature woman
sunlight in hands
man and woman in front of xray
woman with dumbbells